OARS funding Biomed

The purpose of this Dear Colleague Letter is to advise you about funding opportunities at the National Science Foundation for the research community to propose research projects or workshops that will gather data on the implementation and impacts of recent science policy initiatives including, but not limited to those noted earlier.  Especially encouraged are proposals that will: Develop new, or improve existing, analytical frameworks for evaluating the impacts of federal science policy initiatives; Explore different agencies' approaches to the implementation of particular policies to examine how variations in approach affect the achievement of intended policy outcomes; Collect case-study or quantitative data that facilitate identification of best practices in science and innovation policy implementation.

The Barth Syndrome Foundation, Inc. (BSF) and its international affiliates are pleased to announce the availability of funding for basic science and clinical research on the natural history, biochemical basis, and treatment of Barth syndrome. Starting in 2013, there will be two types of grant awards: IDEA grants for 1-2 years and DEVELOPMENT grants for 2-3 years with budgetary maximums of US $50,000 or $100,000, respectively over the full period. BSF's Research Grant Program allows young, non-tenured investigators to include in their submitted budget up to 75% of the direct costs amount as PI salary (10% for established investigators). In addition, for those clinical applications where volunteers must travel to a clinical research site, these travel expenses will be handled separately and will not be included in the application budget limitation. We encourage all investigators at every professional level to submit their best ideas for advancing the state of knowledge about Barth syndrome so that progress can be made in finding a specific treatment or a cure for this unusual mitochondrial disease. There are no geographical limitations to this funding.

BWF's Career Awards at the Scientific Interface provide $500,000 to bridge advanced postdoctoral training and the first three years of faculty service. These awards are intended to foster the early career development of researchers who have transitioned or are transitioning from undergraduate and/or graduate work in the physical/mathematical/computational sciences or engineering into postdoctoral work in the biological sciences, and who are dedicated to pursuing a career in academic research. These awards are open to U.S. and Canadian citizens or permanent residents as well as to U.S. temporary residents.

The pilot research grant is designed to help a basic or clinical scientist in the early stages of their career conduct research that may lead to further funding. Grants can be used for salary support of the principal investigator, as well as direct costs of supplies and equipment.

Five-year $700,000 awards for physician-scientists to bridge advanced postdoctoral/fellowship training and the early years of faculty service. Proposals must be in the area of basic biomedical, disease-oriented, or translational research.  Proposals in health services research or involving large-scale clinical trials are ineligible. Awards are made to degree-granting institutions in the U.S. or Canada on behalf of the awardee.

Shwachman-Diamond Syndrome Foundation (SDSF) is a nonprofit support organization actively helping the victims of this disease. SDSF is accepting grant requests for research relevant to this disease. Any high quality, innovative research proposal deemed relevant to SDS will be considered. The following are areas of particular interest: Investigate or evaluate potential novel therapies or potential novel therapeutic strategies- preferred applications Evaluate predictors of bone marrow abnormalities to determine their correlation with the disease Determine the causes of and investiagte treatments for bone marrow failure and leukemia Evaluate protocols and regimens for bone marrow transplants Evaluate causes and investigate treatments for graft vs host disease and other infections of post bone marrow transplants Investigations related to adult patient presentation, management, and care including transition from pediatric-centered to adult care

The pre-doctoral program supports a research scholar in an established molecular imaging lab that will apply molecular imaging approaches (including tool development) to investigate biological pathways in disease models. The objective is to encourage the integration of imaging approaches in the research of molecular pathways of disease. 

The U.S. Environmental Protection Agency (EPA), as part of its Science to Achieve Results (STAR) program, is seeking applications proposing research to study life stage and/or genetic susceptibility in order to better characterize the sources of human variability in response to chemical exposure. The adverse outcome pathways (AOP) concept has the potential to serve as a framework for using susceptibility indicators, biomonitoring, and high throughput screening (HTS) data in an integrated manner to predict population responses to novel, potentially harmful, chemicals. While much emphasis has been placed on improved biomonitoring and HTS approaches, research is needed to understand the underlying factors that influence human susceptibility and to develop tools and methods for the identification and use of susceptibility indicators in this context. This solicitation provides the opportunity for the submission of applications for projects that may involve human subjects research.

The purpose of this Funding Opportunity Announcement (FOA) is to support a consortium of collaborative projects, with a minimum of two sites, that propose to use cutting edge technologies to generate and analyze whole genome sequencing (WGS) data from either case control or family samples in order to elucidate the full genetic architecture underlying susceptibility to severe mental disorders. Insights into the genetic architecture underlying susceptibility to severe mental disorders will be achieved through implementation of state of the art WGS assays and innovative/novel statistical methods.

The participating NIH Institutes and Centers invite applications to address both the origins and the effects of low level chronic inflammation in the onset and progression of age-related diseases and conditions. Chronic inflammation, as defined by elevated levels of both local and systemic cytokines and other pro-inflammatory factors, is a hallmark of aging in virtually all higher animals including humans and is recognized as a major risk factor for developing age-associated diseases. The spectra of phenotypes capable of generating low-level chronic inflammation and their defining mediators are not clear. Further, a clear understanding of how chronic inflammation compromises the integrity of cells or tissues leading to disease progression is lacking. The role of dietary supplements and/or nutritional status in chronic inflammation in age-related disease is also poorly studied. Thus, there is a critical need to establish the knowledge base that will allow a better understanding of the complex interplay between inflammation and age-related diseases. Applications submitted to this FOA should aim to clarify the molecular and cellular basis for the increase in circulating inflammatory factors with aging, and/or shed light on the cause-effect relationship between inflammation and disease, using pre-clinical (animal or cellular based) models.

The New Scholars Program supports projects to help early- to mid-career women scientists balance family responsibilities with demanding academic careers. New Scholars seeks to actively address the attrition rate of talented women scientists caused by work-life balance issues.

Society for Free Radical Biology and Medicine Travel Awards SFRBM's Outreach Committee are making Travel Awards available to students and postdoctoral fellows who wish to attend SFRBM 2013. Ten (10) awards at $500 each will be presented to postdoc and student SFRBM members in the US. An additional ten (10) awards at $1,000 each will be given by SFRBM to postdoc or student SFRBM members outside the United States -- those eligible include members from Canada, Latin and South America as well as all students and postdocs outside SFRR Americas.

As part of its commitment to young investigators in the field of obesity research, TOS will award a number of travel grants of $500 each to attend the annual meeting. The exact number is set each year by the TOS Council. Potential winners will be selected from the ranking of the submitted abstracts and will need only to return a form signed by their institution acknowledging that the winner is either a graduate student or has received a PhD or MD within the past five years.

Within the framework of the For Women in Science partnership between the L'Oréal Foundation and UNESCO, we are launching the 2014 call for nominations for outstanding women scientist form all over the world. Five 100.000$ prizes will be awarded in march 2014 in Paris to five women scientists, one per region, for the contributions of their research, the strength of their commitments and their impact on society. An international Jury of eminent scientists presided in 2013 by the Nobel Prize winner, Ahmed Zewali, makes the final selection.

The Gideon and Sevgi Rodan Fellowship, a special fellowship to honor the service of two outstanding individuals in the field of bone and mineral research, is given annually to support the research activities of a deserving young investigator. Support is a one-year, non-renewable $40,000USD grant payable to the successful applicant's institution. No overhead may be paid from the fellowship. The research may be basic, translational, clinical, or outcomes-based in bone biology or diseases of the bone. Applicants and their mentors must be members of IBMS or an IBMS Member Society. 

The Vilcek Foundation will award three prizes of $35,000 each to young foreign-born biomedical scientists who demonstrate outstanding early achievement. Eligible work may be in basic, applied, and/or translational biomedical science.

This Funding Opportunity Announcement (FOA) seeks to stimulate innovative research that will increase our understanding of the role that uncultivable bacterial species play in the microbial ecology of the human oral microbiota during states of health and disease. The effective integration of current technologies and the development of new tools and innovative methods are especially encouraged.  Due to the wide spectrum of possible experimental approaches and the multidisciplinary tools that will be required to study this unique microbial population, this FOA is designed specifically to encourage team science that will leverage innovation, broad expertise and multiple technological platforms to answer hypothesis-driven questions regarding these bacteria.  Consistent with this approach, the use of a multiple Program Directors/Principal Investigators (PDs/PIs) model is encouraged that will recruit complementary and collaborative research teams to conduct these studies.  

This Funding Opportunity Announcement (FOA) encourages applications for research awards that are focused on the use the Osteoarthritis Initiative (OAI) database, clinical data and images. This FOA seeks to expand the use of these resources by investigators in the broader research community. Examples of possible topics are: identification and validation of risk factors for knee and hip OA, including both modifiable and non-modifiable risk factors; utilization of biospecimens in conjunction with research efforts to determine biochemical markers of early and/or progressive disease; analyses of existing OAI data to assess the effectiveness of biobehavioral, pharmacological, and other interventions that subjects use in response to OA pain; determination of predictive role of MRI changes for subsequent radiographic and clinical outcome changes related to development of knee OA; development of novel and efficient tools for analysis of MR images and x rays that can be applied to large numbers of images with high degrees of reproducibility for diagnosis and monitoring of OA-related changes; and research focused on the trajectory of disease including effects on other joint structures such as muscles, ligaments, and bone, with regard to points where interventions could be made, especially for subsets, to reduce OA severity. The publication of this FOA to the research co

This Funding Opportunity Announcement (FOA) encourages applications focused on the use the Osteoarthritis Initiative (OAI) database, clinical data and images. This FOA seeks to expand the use of these resources by investigators in the broader research community. Examples of possible topics are: identification and validation of risk factors for knee and hip OA, including both modifiable and non-modifiable risk factors; utilization of biospecimens in conjunction with research efforts to determine biochemical markers of early and/or progressive disease; analyses of existing OAI data to assess the effectiveness of biobehavioral, pharmacological, and other interventions that subjects use in response to OA pain; determination of predictive role of MRI changes for subsequent radiographic and clinical outcome changes related to development of knee OA; development of novel and efficient tools for analysis of MR images and x rays that can be applied to large numbers of images with high degrees of reproducibility for diagnosis and monitoring of OA-related changes; and research focused on the trajectory of disease including effects on other joint structures such as muscles, ligaments, and bone, with regard to points where interventions could be made, especially for subsets, to reduce OA severity. The publication of this FOA to the research community indicates to investigators and peer reviewers the importance that the NIAMS and other partners have placed on the use of the OAI resources.

The Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) and participating Institutes invite grant applications for research on the development of safe, real-time, non-invasive (or minimally invasive), in vivo methods to assess the development and function of the human placenta.